Potassium chloride - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for potassium chloride and what is the scope of freedom to operate?
Potassium chloride
is the generic ingredient in forty-four branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Glenmark Pharms Ltd, Granules, Lannett Co Inc, Lupin Ltd, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Pharma Res Software, Rubicon, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Nexus Pharms, Icu Medical Inc, Apotex, Genus Lifesciences, Pharm Assoc, Saptalis Pharms, Wes Pharma Inc, Future Pak, Abbvie, Apothecon, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Breckenridge, Copley Pharm, Guangzhou Novaken, Mylan, Schering, Sigmapharm Labs Llc, Vitruvias Therap, Yichang Humanwell, and Novartis, and is included in one hundred and twenty-three NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-four drug master file entries for potassium chloride. Eighty-six suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for potassium chloride
US Patents: | 0 |
Tradenames: | 44 |
Applicants: | 59 |
NDAs: | 123 |
Drug Master File Entries: | 24 |
Finished Product Suppliers / Packagers: | 86 |
Raw Ingredient (Bulk) Api Vendors: | 333 |
Patent Applications: | 300 |
Drug Prices: | Drug price trends for potassium chloride |
Drug Sales Revenues: | Drug sales revenues for potassium chloride |
What excipients (inactive ingredients) are in potassium chloride? | potassium chloride excipients list |
DailyMed Link: | potassium chloride at DailyMed |
Generic filers with tentative approvals for POTASSIUM CHLORIDE
Applicant | Application No. | Strength | Dosage Form |
See Plans and Pricing | See Plans and Pricing | 20MEQ | Tablet; Oral |
See Plans and Pricing | See Plans and Pricing | 10MEQ | Tablet, Extended Release; Oral |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for potassium chloride
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for potassium chloride
Expired US Patents for potassium chloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Nesher Pharms | MICRO-K | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 018238-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
Schering | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019439-002 | Jun 13, 1986 | See Plans and Pricing | See Plans and Pricing |
Schering | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 019439-001 | Jun 13, 1986 | See Plans and Pricing | See Plans and Pricing |
Nesher Pharms | MICRO-K 10 | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 018238-002 | May 14, 1984 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.